Smart & Biggar are most popular:
- with Senior Company Executives and HR
- with readers working within the Business & Consumer Services industries
Section 8 Proceedings:
- FAMPYRA (fampridine): Taro Pharmaceuticals v Biogen and Acorda Therapeutics
PM(NOC) Proceedings:
- TRINTELLIX (vortioxetine): Lundbeck v Sandoz Canada
- ODEFSEY (emtricitabine / rilpivirine / tenofovir alafenamide): Janssen Pharmaceutical v Apotex
- DESCOVY (tenofovir alafenamide hemifurate): Gilead Sciences v Apotex
- ODEFSEY (emtricitabine / rilpivirine / tenofovir alafenamide): Gilead Sciences v Apotex
For complete details about these proceedings, click here.
The preceding is intended as a timely update on Canadian intellectual property and technology law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.
